RNWEX | WAEMX | RNWEX / WAEMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 17 years | - |
Gain YTD | 6.819 | -1.320 | -517% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 60.9B | 320M | 19,031% |
Annual Yield % from dividends | 1.24 | 0.00 | - |
Returns for 1 year | 11.20 | 10.74 | 104% |
Returns for 3 years | -15.12 | -35.60 | 42% |
Returns for 5 years | 16.22 | 4.71 | 344% |
Returns for 10 years | 39.20 | 10.92 | 359% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSDUX | 13.25 | -0.07 | -0.53% |
Morgan Stanley Emerging Mkt ex China I | |||
FEVAX | 22.58 | -0.14 | -0.62% |
First Eagle US Value A | |||
ALGAX | 19.55 | -0.24 | -1.21% |
Alger International Opportunities A | |||
HRCCX | 30.41 | -0.64 | -2.06% |
Carillon ClariVest Capital Apprec C | |||
JFNNX | 74.15 | -2.12 | -2.78% |
Janus Henderson Global Life Sciences N |